Veloxis Pharmaceuticals A/S Logo

Email this page: News Release

Veloxis Pharmaceuticals Announces Amended and Restated Loan and Security Agreement

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Veloxis Pharmaceuticals A/S for any marketing purposes.

Send:       


 
This helps Veloxis Pharmaceuticals A/S prevent automated submissions.